• Bone Biologics will hold its annual shareholder meeting in Burlington, Massachusetts on Aug. 11, 2026, covering the fiscal year ended Dec. 31, 2025.
• Shareholders will vote to elect four directors to the board.
• An advisory vote on executive compensation is also scheduled.
• Investors will vote on ratifying Weinberg & Company as independent registered public accounting firm for the 2026 fiscal year.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bone Biologics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-031652), on July 02, 2026, and is solely responsible for the information contained therein.